Nasdaq

Berkeley Lights Launches Beacon Select™, A New Optofluidic System For Cell Line Development

New, two-chip, single-cell optofluidic system ideal for small- to mid-sized biopharma & CDMOs/CROs to affordably gain access to the Beacon® technology and cell line development-specific applications ...
Seeking Alpha

Berkeley Lights to Showcase its New Beacon® System Workflow to Access Broad B Cell Diversity to Rapidly Identify High-Value Rabbit Monoclonal Antibodies at 2022 Antibody ...

EMERYVILLE, Calif., Nov. 30, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (BLI), a leader in digital cell biology, today announced its participation at the upcoming Antibody Engineering & Therapeutics ...
Nasdaq

Berkeley Lights Debuts in France as MImAbs Acquires the Beacon® Optofluidic System for Antibody Discovery

EMERYVILLE, Calif. and MARSEILLE, France, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and MImAbs SAS, an emerging CRO that discovers and ...
NBC4 Columbus

Monash University Implements Antibody Discovery Application by Utilizing the Berkeley Lights Beacon® Platform

EMERYVILLE, Calif. and MELBOURNE, Australia, Nov. 9, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Monash University, one of Australia's ...
Business Insider

Biocytogen announces acquisition of a third Beacon Optofluidic system to support expanding Antibody Discovery Platform

BOSTON, Feb. 25, 2021 /PRNewswire/ -- Biocytogen, a company dedicated to accelerating therapeutic antibody discovery, has announced the acquisition of a third Beacon Optofluidic system. The new ...
Business Wire

Abveris Deploys the Berkeley Lights Beacon® Platform for Antibody Discovery

CANTON, Mass.--(BUSINESS WIRE)--Abveris, Inc., a leader in contract research antibody discovery, today announced the deployment of the Berkeley Lights, Inc. Beacon® optofluidic platform for antibody ...